It's hard to argue with the kinds of results Eli Lilly (NYSE: LLY) has produced over the past five years. The company has been one of the best-performing pharmaceutical giants, with its shares ...

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now ...

Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here. Eli Lilly and Co. has begun selling its blockbuster ...

Caitlin Clark may be an all-star on the basketball court, but she couldn’t beat Eli Manning when it came to a game of Pop-A-Shot. On the latest episode of The Eli Manning Show, the former NFL ...

Eli Lilly (LLY) ended the recent trading session at $912.76, demonstrating a -1.82% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 1. ...

If anyone still dares to view the hostages as anything but a nonpartisan, non-negotiable issue, they must watch freed hostage Eli Sharabi’s interview with the investigative team of Channel 12 ...

Eli Sharabi was “echoing Hamas propaganda” when he spoke about his experiences in captivity during an interview with Channel 12’s Uvda last Thursday, former national security minister Itamar ...

Magnet Biomedicine announced Friday it has reached a licensing agreement worth up to $1.25B with Eli Lilly (NYSE:LLY) to develop cancer drugs leveraging the company’s TrueGlue discovery platform.

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

COLUMBIA, S.C. (WIS) - The Richland County Sheriff’s Department (RCSD) is investigating a stabbing that took place at the Alvin S. Glenn Detention Center on Thursday. Deputies said jail staff ...

The molecular glue wave that first began years ago is still swelling, with Eli Lilly earmarking approximately $1.25 billion to develop new versions of the sticky molecules in collaboration with ...